Suscribirse

The experience of diagnosis announcement in rare endocrine diseases: A survey of the French FIRENDO network - 22/02/24

Doi : 10.1016/j.ando.2023.10.008 
Haifa Rahabi a, Maria Givony b, Béatrice Demaret h, Frédérique Albarel a, Marie-Reine Aubron d, Beate Bartès e, Lucie Bernard f, Hendy Abdoul c, Naim Bouazza c, Philippe Brun g, Delphine Drui i, Véronique Dujardin j, Catherine Lançon k, Sabine Malivoir l, Irène Netchine l, Bénédicte Perrotin m, Virginie Picard n, Rachel Reynaud o, u, Murielle Ribeiro p, Véronique Tardy Guidollet q, Amélie Victor r, Jérôme Bertherat b, s, Claudine Colin t, Thierry Brue a, u,
a Service d’endocrinologie, hôpital de la Conception, centre de référence des maladies rares de l’hypophyse HYPO, Assistance Publique–Hôpitaux de Marseille (AP–HM), 13005 Marseille, France 
b Service d’endocrinologie, filière santé maladies rares endocriniennes FIRENDO, Assistance Publique–Hôpitaux de Paris, Groupe hospitalo-universitaire AP–HP Centre, Hôpital Cochin, 75014 Paris, France 
c URC Paris Descartes Necker/Cochin, hôpital Tarnier, 75006 Paris, France 
d Association Craniopharyngiome-solidarité, 65000 Tarbes, France 
e Association Vivre sans Thyroïde, 31490 Léguevin, France 
f MAIA: Association pour aider toutes personnes confrontées à l’infertilité, 61140 Bagnoles de l’Orne, France 
g Association ASSYMCAL: Syndrome de Mc Cune Albright dysplasie fibreuse de l’os, 85000 La Roche sur Yon, France 
h Association GRANDIR, 92600 Asnières-sur-Seine, France 
i Service d’endocrinologie, l’institut du thorax, centre hospitalier universitaire de Nantes, Boulevard Jacques Monod, 44093 Nantes Cedex, France 
j Valentin APAC: Association de Porteurs d’Anomalies Chromosomiques, 95610 Eragny-sur-Oise, France 
k Acromégales, Pas Seulement..., association nationale de l’acromégalie reconnue d’intérêt général, 59234 Villers-au Tertre, France 
l Assistance Publique–Hôpitaux de Paris, hôpital Armand Trousseau, 75571 Paris, France 
m AFIF SSR/PAG: Association Française des Familles touchées par le Syndrome de Silver Russell (SSR) et des personnes nées Petites pour l’Age Gestationnel (PAG) et leurs amis, 30390 Domazan, France 
n Association du Syndrome de Wolfram, 56390 Grand-Champ, France 
o Service de pédiatrie multidisciplinaire, hôpital de la Timone Enfants, centre de référence des maladies rares de l’hypophyse HYPO, Assistance Publique–Hôpitaux de Marseille (AP–HM), 13005 Marseille, France 
p Plateforme PRIOR, Centre Hospitalier Universitaire d’Angers, 49000 Angers, France 
q Hospices Civils de Lyon (HCL), laboratoire de biologie médical multisites, centre de référence DEV-GEN, 69677 Bron, France 
r Association syndrome de Rokitansky- MRKH, 75013 Paris, France 
s Service d’endocrinologie, centre de référence maladies rares de la Surrénale, 75014, Paris France. Université Paris Cité, Inserm U1016, CNRS UMR 8104, Institut Cochin, Génomique et Signalisation des Tumeurs Endocrines, Assistance Publique–Hôpitaux de Paris, Groupe hospitalo-universitaire AP–HP Centre, Hôpital Cochin, Paris, France 
t Association Surrénales, 35200 Rennes, France 
u Aix-Marseille Université, Institut National de la Santé et de la Recherche Médicale (Inserm), U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), Marseille, France 

Corresponding author at: Department of Endocrinology, Hôpital de la Conception, 147, Boulevard Baille, 13005 Marseille, France.Department of Endocrinology, Hôpital de la Conception147, Boulevard BailleMarseille13005France

Abstract

Context

Diagnosis announcement of a chronic disease is a crucial moment for patients as well as for their families and an important step in the management of severe conditions such as rare endocrine diseases. Little is known of how diagnosis is communicated to patients and families. The FIRENDO network was created by the third French Plan for Rare Diseases, to promote autonomy, care and research on rare endocrine diseases.

Objectives

The aim of this study was to characterize, for the first time, the experience and needs of patients and/or their parents around the announcement of diagnosis to ensure optimal quality of care.

Methods

A quantitative self-administered survey on diagnosis announcement procedures in rare endocrine diseases was launched in April 2017 by the ad hoc FIRENDO thematic working group in collaboration with its 11 partnering patient associations and support groups. The questionnaire was designed and revised by patient support group representatives, adult and pediatric endocrinologists, psychologists and biologists, all expert in rare endocrine diseases. It was made available on the FIRENDO network website and distributed mainly by email with electronic links on their respective websites to members of all affiliated patient support groups.

Results

Questionnaires were filled out by 391 patients and 223 parents (median age of patients: 39 years). The following conditions were associated with at least 30 answers: Addison's disease, classical forms of congenital adrenal hyperplasia (CAH), Russell-Silver syndrome, Cushing's syndrome, acromegaly and craniopharyngioma. Overall, some announcement modalities were judged favorably by patients: physician's empathy, availability and use of clear terms, and presence of family at the time of announcement. However, a lack of psychological care and information documents was reported, as well as some inadequate procedures such as postal mail announcements.

Conclusion

This work suggests that better knowledge of the patient's experience is useful for improving the diagnosis announcement of rare endocrine disorders. The main recommendations derived from the survey were the need for several announcement visits, information on patient support groups and reference centers, imperatively avoiding impersonal announcement, and the usefulness of a written accompanying document.

El texto completo de este artículo está disponible en PDF.

Keywords : Diagnosis announcement, Rare disease, Endocrine disease, Addison's disease, Congenital adrenal hyperplasia, Russell-Silver syndrome, Cushing's syndrome, Acromegaly, Craniopharyngioma


Esquema


© 2024  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 85 - N° 1

P. 27-35 - février 2024 Regresar al número
Artículo precedente Artículo precedente
  • Diagnostic performance of an automated immunoassay for salivary cortisol
  • Christelle Laguillier-Morizot, Fidéline Bonnet-Serrano, Marie-Clémence Leguy, Miliça Simeonovic, Catherine Sée, Corinne Zientek, Mickael Soussan, Lucas Bouys, Jérôme Bertherat, Jean Guibourdenche
| Artículo siguiente Artículo siguiente
  • Mortality-related risk factors of inpatients with diabetes and COVID-19: A multicenter retrospective study in Belgium
  • Thomas Servais, France Laurent, Thomas Roland, Camelia Rossi, Elodie De Groote, Valérie Godart, Ernestina Repetto, Michel Ponchon, Pascale Chasseur, Laurent Crenier, Sandrine Van Eeckhoudt, John Yango, Philippe Oriot, Mirela Morisca Gavriliu, Stéphanie Rouhard, Benjamin Deketelaere, Dominique Maiter, Michel Paul Hermans, Jean Cyr Yombi, Laura Orioli

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.